Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
2016 · New England Journal of Medicine · 1,029 citations
https://doi.org/10.1056/nejmoa1610227
C
Charles A. Simonton
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
127
Papers
11.2K
Citations
50
h-index
78
i10-index
Charles A. Simonton is an academic researcher from Johnson & Johnson (United States). The author has contributed to research in topics: Coronary Interventions and Diagnostics & Cardiac Imaging and Diagnostics & Cardiac Valve Diseases and Treatments. The author has an h-index of 50, co-authored 108 publications.
Papers by this author
worksEverolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease
2010 · New England Journal of Medicine · 886 citations
https://doi.org/10.1056/nejmoa0910496
Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization
2020 · Journal of the American College of Cardiology · 117 citations
https://doi.org/10.1016/j.jacc.2020.08.016
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial
2019 · European Heart Journal · 80 citations
https://doi.org/10.1093/eurheartj/ehz113
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent
2020 · JACC: Cardiovascular Interventions · 20 citations
https://doi.org/10.1016/j.jcin.2019.09.047
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat